跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abrexin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abrexin
Approved
STANDARD
Abrexin
Square Pharmaceuticals, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b2e8d0172c0f5fc3
Company
Square Pharmaceuticals, Inc.
Type
Standard
Approval Details
Approval Id
b2e8d0172c0f5fc3
Drug Approval Philippines Name
Abrexin
Product Name
Abrexin
Registration Number
DRP-1325
Brand Name
Abrexin
Generic Name
Ambroxol Hydrochloride
Dosage Form
Tablet
Dosage Strength
30mg
Manufacturer
Square Pharmaceuticals, Inc.
Issuance Date
27 April 2021
Expiry Date
24 March 2026
Pharmacologic Category
Mucolytic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b2e8d0172c0f5fc3
Type
Standard
Back to Philippines FDA Approvals